• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research.

作者信息

Lambiase Pier D

机构信息

Section Editor, Arrhythmia Risk Stratification, Arrhythmia & Electrophysiology Review Institute of Cardiovascular Science, University College London, London, UK; Barts Heart Centre, West Smithfield, London, UK.

出版信息

Arrhythm Electrophysiol Rev. 2021 Jul;10(2):63-64. doi: 10.15420/aer.2021.29.

DOI:10.15420/aer.2021.29
PMID:34401176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8353549/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0b/8353549/01cd21268ac7/aer-10-63-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0b/8353549/01cd21268ac7/aer-10-63-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0b/8353549/01cd21268ac7/aer-10-63-g001.jpg

相似文献

1
Maximising Opportunities Post Coronavirus Disease 2019: Time to Embrace a New Era of Atrial Fibrillation Research.最大化2019冠状病毒病后的机遇：拥抱心房颤动研究新时代的时候到了。
Arrhythm Electrophysiol Rev. 2021 Jul;10(2):63-64. doi: 10.15420/aer.2021.29.
2
Moving forward: embracing challenges as opportunities to improve medical education in the post-COVID era.向前迈进：将挑战视为后新冠疫情时代改善医学教育的机遇。
Humanit Soc Sci Commun. 2022;9(1):419. doi: 10.1057/s41599-022-01451-7. Epub 2022 Nov 26.
3
Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial.房性期前收缩可预测隐源性卒中的心房颤动：来自 EMBRACE 试验的结果。
Stroke. 2015 Apr;46(4):936-41. doi: 10.1161/STROKEAHA.115.008714. Epub 2015 Feb 19.
4
"": Anticoagulation Management in Patients with Atrial Fibrillation and Prosthetic Valves in the Era of Direct Oral Anticoagulants.“”：直接口服抗凝剂时代的心房颤动和人工瓣膜患者的抗凝管理。
Medicina (Kaunas). 2019 Aug 4;55(8):437. doi: 10.3390/medicina55080437.
5
Coronavirus Disease and New-Onset Atrial Fibrillation: Two Cases.冠状病毒病与新发心房颤动：两例报告
Cureus. 2020 May 12;12(5):e8066. doi: 10.7759/cureus.8066.
6
COVID-19 and ENT SLT services, workforce and research in the UK: A discussion paper.COVID-19 与英国的耳鼻喉 SLT 服务、劳动力和研究：讨论文件。
Int J Lang Commun Disord. 2020 Sep;55(5):806-817. doi: 10.1111/1460-6984.12565. Epub 2020 Aug 8.
7
Gender Differences in Atrial Fibrillation: A Review of Epidemiology, Management, and Outcomes.心房颤动中的性别差异：流行病学、管理及结局综述
Curr Cardiol Rev. 2019;15(2):136-144. doi: 10.2174/1573403X15666181205110624.
8
Underestimation of the incidence of new-onset post-coronary artery bypass grafting atrial fibrillation and its impact on 30-day mortality.冠状动脉旁路移植术后新发心房颤动发生率的低估及其对 30 天死亡率的影响。
J Thorac Cardiovasc Surg. 2017 Oct;154(4):1260-1266. doi: 10.1016/j.jtcvs.2017.05.104. Epub 2017 Jun 13.
9
European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care.欧洲初级保健心血管学会（EPCCS）关于初级保健中房颤（AF）患者卒中预防（SPAF）的共识指南。
Eur J Prev Cardiol. 2016 Mar;23(5):460-73. doi: 10.1177/2047487315571890. Epub 2015 Feb 20.
10
Atrial Arrhythmias in a Patient Presenting With Coronavirus Disease-2019 (COVID-19) Infection.一名新型冠状病毒肺炎（COVID-19）感染患者的房性心律失常
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620925571. doi: 10.1177/2324709620925571.

本文引用的文献

1
Reconceptualising Atrial Fibrillation Using Renewal Theory: A Novel Approach to the Assessment of Atrial Fibrillation Dynamics.运用更新理论重新认识心房颤动：一种评估心房颤动动态变化的新方法
Arrhythm Electrophysiol Rev. 2021 Jul;10(2):77-84. doi: 10.15420/aer.2020.42.
2
The changing perspective of clinical trial designs.临床试验设计不断变化的视角。
Perspect Clin Res. 2021 Apr-Jun;12(2):66-71. doi: 10.4103/picr.PICR_138_20. Epub 2021 Jan 8.
3
Mobile health technology-supported atrial fibrillation screening and integrated care: A report from the mAFA-II trial Long-term Extension Cohort.
移动医疗技术支持的心房颤动筛查和综合护理：来自 mAFA-II 试验长期扩展队列的报告。
Eur J Intern Med. 2020 Dec;82:105-111. doi: 10.1016/j.ejim.2020.09.024. Epub 2020 Oct 13.
4
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice.CASTLE-AF 试验的可推广性：在常规实践中对患有心房颤动和心力衰竭的患者进行导管消融。
Heart Rhythm. 2020 Jul;17(7):1057-1065. doi: 10.1016/j.hrthm.2020.02.030. Epub 2020 Mar 4.
5
Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial.基层医疗中房颤的综合管理：ALL-IN整群随机试验的结果
Eur Heart J. 2020 Aug 7;41(30):2836-2844. doi: 10.1093/eurheartj/ehaa055.
6
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者死亡率、卒中和出血及心搏骤停的影响：CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.
7
Continuous monitoring after atrial fibrillation ablation: the LINQ AF study.心房颤动消融术后的连续监测：LINQ-AF 研究。
Europace. 2018 Nov 1;20(FI_3):f312-f320. doi: 10.1093/europace/euy038.
8
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.